Insider sale
NEWAMSTERDAM PHARMA CO N.V.
$36.81M
1.74M shares
What this filing means
NAP POOLCO B.V. plans to sell 1.74M shares of NEWAMSTERDAM PHARMA CO N.V. valued at approximately $36.81M. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 7/14/2025ACC: 0001969223-25-000508
1.74M
Shares to sell
$36.81M
Approx. market value
1.43M
Acquired (3 months)
1
Planned
1 completed
Securities Acquired — Last 3 Months1
Initial Public Offering
Cash
11/15/2022
1.43MTotal acquired1.43M
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
11/15/2022 | Initial Public Offering Cash | 1.43M | — |
| Total | 1.43M | ||
Planned & Completed Dispositions2
Completed
—Completed
Units to sell
303.20K
Market value
$5.91M
6/16/2025
Planned — Approximate Date
NasdaqPlanned
Units to sell
1.43M
Market value
$30.90M
7/14/2025
Total
Units
1.74M
Value
$36.81M
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
| Completed | ||||
6/16/2025 | 303.20K | $5.91M | — | Completed |
| Planned — Approximate Date | ||||
7/14/2025 | 1.43M | $30.90M | Nasdaq | Planned |
| Total | 1.74M | $36.81M | ||